Friday, 16 January 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 16 January 2026
News

Global exec takes top Aussie job

Posted 16 January 2026 AM

After a quarter of a century at MSD, global pharma executive David Peacock has been named CEO of Australian biotech Vaxxas as it moves to disrupt the industry with its revolutionary vaccine patch.

The high-flying executive finished up as MSD's Senior Vice President, Global Vaccines last September and prior to that held a string of senior roles including President, Asia Pacific and Managing Director UK & Ireland.

To see the whole article, please login

Popular

Skills gap threatening pharma
First Aussie redundancies of 2026
Who earned most from the PBS?
Global exec takes top Aussie job
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home